Literature DB >> 1279176

Inhibition of rat alveolar macrophage phagocytic function by a Pseudomonas cepacia lipase.

D C Straus1, M K Lonon, J C Hutson.   

Abstract

The effects of purified Pseudomonas cepacia lipase on rat pulmonary alveolar function and morphology were examined. Lipase (2.5-20 micrograms/ml) adversely effected the phagocytic function of rat pulmonary alveolar macrophages in a dose-dependent manner. The lipase itself was not directly cytotoxic to these cells. Alveolar macrophages, in the absence of lipase, phagocytosed c. 35% of a given population of opsonised P. cepacia in 30 min when the ratio of bacteria:phagocyte was 10:1. Phagocytosis of P. cepacia by rat pulmonary alveolar macrophages was significantly reduced when the cells were either pre-incubated with the lipase or when phagocytosis occurred in the presence of the lipase. This was confirmed by transmission electronmicroscopy. These functional changes were associated with marked alterations of the macrophage morphology. Scanning electronmicroscopy showed that macrophages exposed to the P. cepacia lipase had fewer specialised surface structures and did not spread on plastic surfaces as well as untreated macrophages. The effects of the lipase were lost after heat inactivation, which indicates that the effects of the P. cepacia lipase were due to its enzymic activity. These results suggest that, if sufficient quantities of the enzyme are produced in vivo, lipase may be an important virulence factor for P. cepacia, allowing the organism to evade phagocytic cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279176     DOI: 10.1099/00222615-37-5-335

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  10 in total

1.  Effects of growth rate and nutrient limitation on virulence factor production in Burkholderia cepacia.

Authors:  D McKenney; D G Allison
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490

2.  Identification, characterization, and expression of a unique secretory lipase from the human pathogen Leishmania donovani.

Authors:  Alison M Shakarian; Glen C McGugan; Manju B Joshi; Mary Stromberg; Lauren Bowers; Christine Ganim; Jessica Barowski; Dennis M Dwyer
Journal:  Mol Cell Biochem       Date:  2010-03-27       Impact factor: 3.396

Review 3.  Plesiomonas shigelloides Revisited.

Authors:  J Michael Janda; Sharon L Abbott; Christopher J McIver
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

4.  Correlation between an in vitro invasion assay and a murine model of Burkholderia cepacia lung infection.

Authors:  Martin V Cieri; Nicole Mayer-Hamblett; Adam Griffith; Jane L Burns
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

5.  Potential virulence-associated properties of Plesiomonas shigelloides strains.

Authors:  I Ciznár; A Hostacka; C Gonzalez-Rey; K Krovacek
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

6.  Lipopolysaccharide of Burkholderia cepacia and its unique character to stimulate murine macrophages with relative lack of interleukin-1beta-inducing ability.

Authors:  H Shimomura; M Matsuura; S Saito; Y Hirai; Y Isshiki; K Kawahara
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

7.  The in vitro effect of imipenem and ofloxacin on enzymic activity of Klebsiella strains.

Authors:  A Hostacká
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

8.  Role of lipase in Burkholderia cepacia complex (Bcc) invasion of lung epithelial cells.

Authors:  T Mullen; K Markey; P Murphy; S McClean; M Callaghan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-12       Impact factor: 3.267

Review 9.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

10.  Tuberculosis alters pancreatic enzymes in the absence of pancreatitis.

Authors:  Modisa S Motswaledi; Rosinah Sekgwama; Ishmael Kasvosve
Journal:  Afr J Lab Med       Date:  2014-10-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.